| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 33,625 | 32,483 | 39,263 | 36,637 | | Cost of Revenue | 17,949 | 18,089 | 18,605 | 17,437 | | | Gross Profit | 15,676 | 14,394 | 20,658 | 19,200 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 14,636 | 14,301 | 17,440 | 17,427 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 326 |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,040 | 93 | 3,218 | 1,773 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 51 | (252) | (3,009) | 1,307 | | Earnings Before Interest And Taxes | 872 | (77) | 209 | 2,084 | | Interest Expense | 669 | 1,283 | 1,417 | 2,371 | | Income Before Tax | 203 | (1,360) | (1,208) | (287) | | Income Tax Expense | 429 | 372 | 782 | (1,406) | | Minority Interest | 19 | 16 |
-
|
-
| | | | Net Income From Continuing Ops | (4,591) | (1,716) | (1,990) | 1,119 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (207) | (1,716) | (1,990) | 1,119 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($207) | ($1,716) | ($1,990) | $1,119 |
|
0.31% Nasdaq 0.00%
Income Statement
